Shares ofNurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia.
Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.
- Interactive Strength Inc. (NASDAQ:TRNR) shares rose...
Login or create a forever free account to read this news
Sign up/Log in